Neoplasia Flashcards

1
Q

Contrast the general features of benign vs malignant tumours

A

Benign: locally expansile, slow growth, often well circumscribed (+/- capsule), well differentiated cells, unable to metastasise
Malignant: locally invasive, often poorly circumscribed, can be necrotic, variable differentiation, potential to metastasise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the 3 main modes of metastasis?

A

Lymphatic
Haematogenous
Transcoelomic (through membranes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

List 8 histopathological features of neoplasia

A
Large nuclei
Pleomorphic nuclei (vary in size and shape)
Coarser nuclear chromatin
Hyperchromatic nuclei
Prominent nucleoli
Abnormal mitotic figures
Architectural disorganisation
Desmoplastic stroma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are anaplastic cells?

A

Completely undifferentiated cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What prefix is used for a glandular tumour?

A

Adeno

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What prefix is used for a smooth muscle tumour?

A

Leiomyo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What prefix is used for a osteoblastic (osteoid-forming) tumour?

A

Osteo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What suffix is used for a benign tumour?

A

-oma (there are some exceptions to this, e.g. lymphoma)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What suffix is used for a malignant epithelial tumour?

A

Carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What suffix is used for a malignant mesenchymal tumour?

A

Sarcoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are 2 characteristic histological features of glandular tumours?

A

Formation of glandular lumina

Signet ring cells producing mucin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are 3 characteristic histological features of squamous cell tumours?

A

Eosinophilic cytoplasm
Keratinisation
Intercellular bridges

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What does tumour grade measure?

A

Degree of differentiation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is an in situ carcinoma?

A

Generally refers to severe (grade 3) dysplasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How do neoplasms invade past the basement membrane?

A

Can degrade the BM via release of matrix metalloproteinases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

When are polyps commonly formed?

A

When glandular dysplastic lesions occur in epithelia lining organs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the 4 classes of normal regulatory genes relevant to carcinogenesis?

A

Growth-promoting proto-oncogenes
Growth-inhibiting TSGs
Genes regulating apoptosis
DNA repair genes

18
Q

Give 3 examples of TSGs

A

p53
Rb
APC

19
Q

Give 3 examples of oncogenes

A

HER2
Ras
Myc

20
Q

Given an example of a DNA repair gene

A

BRCA (1, 2)

21
Q

What is the difference between a mutation and a polymorphism in cancer genetics?

A

Mutation: any change in a DNA sequence away from normal (implies there is a normal allele that is prevalent in the population), involved in pathogenesis of cancer
Polymorphism: DNA sequence variation common in the population (no single allele is considered standard), influences RISK of cancer

22
Q

What is responsible for the slow progression in low growth fraction tumours?

A

Cell production vs. death occurs at a similar rate

23
Q

Give 3 examples of high growth fraction tumours

A

Leukaemias
Lymphomas
Small-cell carcinoma

24
Q

Give 2 examples of low growth fraction tumours

A

Colon

Breast adenocarcinoma

25
Q

What are oncogenes?

A

Mutant versions of proto-oncogenes that function autonomously without a requirement for normal growth-promoting signals

26
Q

Give 5 examples of common (normal physiological) roles of oncogenes

A
Growth factors (acting in autocrine manner)
Growth factor receptors
Signal transduction proteins
TFs
Cyclins and CDKs
27
Q

What is loss of heterozygosity (LOH)?

A

Loss of normal function of 1 allele of a gene in which the other allele was already inactivated

28
Q

What is p53 and what is its role?

A

TF which can regulate the expression of cell cycle factors

Involved in apoptosis, cell-cycle arrest, DNA repair, differentiation and senescence

29
Q

What are some of the mechanisms regulating TSG expression?

A

miRNA-mediated control

Epigenetic control

30
Q

What are 6 mechanisms used by neoplasms to evade apoptosis?

A

IMAGE
Reduced CD95 level
Inactivation of death-induced signalling complex by FLICE protein
Upregulation of anti-apoptotic Bcl-2
Reduced levels of pro-apoptotic BAX resulting from loss of p53
Loss of APAF-1
Upregulation of inhibitors of BAX

31
Q

How do tumour cells develop immortality?

A

Via reactivation of telomerase

32
Q

What is the molecular mechanism underlying metastasis?

A

Detachment: via disruption of cellular “glue” (cadherins, beta-catenin, connexins)
Degradation of ECM
Attachment to novel ECM components
Migration of tumour cells

33
Q

What are some popular therapeutic targets for cancer and what is the role of these targets?

A

VEGFs, VEGF receptors

Involved in tumour angiogenesis

34
Q

List 10 characteristics of tumours and the classes of therapeutics used to target them

A

Sustaining proliferative signalling: EGFR inhibitors
Evading growth suppressors: CDK inhibitors
Avoiding immune destruction: immune-activating anti-CTLA4 mAb
Enabling replicative immortality: telomerase inhibitors
Tumour-promoting inflammation: selective anti-inflammatory drugs
Activating invasion and metastasis: inhibitors of HGF/c-Met
Inducing angiogenesis: inhibitors of VEGF signalling
Genome instability and mutation: PARP inhibitors
Resisting cell death: pro-apoptotic BH3 mimetics
Deregulating cellular energetics: aerobic glycolysis inhibitors

35
Q

What causes weight loss and anorexia in cancer?

A

TNF-a, IL-1 produced by tumour cells or cells in the tumour microenvironment

36
Q

What are the 4 important diagnostic/prognostic factors to determine following a diagnosis of malignancy?

A

Specific tumour type and subtype (cell lineage)
Grade
Stage
Presence of lymphovascular invasion

37
Q

What does tumour stage measure?

A

Refers to the progression the malignancy has made in terms of local spread and metastasis

38
Q

What is the most common staging system used?

A

TNM

39
Q

What are the criteria of the TNM staging system?

A

T: extent of primary tumour (T0-T4 indicating size and local extent)
N: regional LN metastases (N0-N3)
M: absence or presence of distant metastases (M0-M1)
X indicates cannot be assessed or unknown
Components are combined to give a stag grouping, usually from I-IV

40
Q

What are some prognostic factors in cancer?

A

Vascular invasion seen in primary tumour

Specific genetic alterations

41
Q

What are the 2 main categories of targeted therapies for cancer?

A

Small molecules that e.g. inhibit GF receptors or TK

Monoclonal antibodies that target specific proteins or receptors

42
Q

When does metaplasia arise?

A

Response to chronic injury (e.g. GORD, chronic gastritis, chronic inflammation, smoking)
Can be physiological (e.g. cervical transformation zone)